Is a
Patent attributes
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
July 10, 2012
Patent Application Number
12739383
Date Filed
October 20, 2008
Patent Citations Received
Patent Primary Examiner
Patent abstract
Disclosed herein are fully human antibodies and antigen-binding fragments thereof that specifically bind human VEGF and inhibit VEGF binding to VEGF-R1 and VEGF-R2, and therefore inhibit VEGF signaling. The antibodies and antigen-binding fragments disclosed herein may be used, for example, to treat angiogenesis and conditions associated with angiogenesis both in vivo and in vitro.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
